Direct effects of secretory products of immune cells on neurons and glia

Journal of the Neurological Sciences

Volumn 333, Issue 1-2, 2013, Pages 30-36

  Benjamins, Joyce A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cells; Cytokines; FAT10; Glia; IL 6 signal transducer; Multiple sclerosis; Neuroimmunology; Neurons

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GROWTH FACTOR; IMMUNE RELATED MOLECULE; NEUROTROPHIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CYTOKINE RELEASE; DEATH; DOWN REGULATION; GENE EXPRESSION; GLIA CELL; HUMAN; HYPOTHESIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; MACROGLIA; MAGNITUDE ESTIMATION METHOD; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL CULTURE; NERVE CELL LESION; NEUROIMMUNOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; SUPERNATANT; SYSTEMATIC REVIEW;

B CELLS; CYTOKINES; FAT10; GLIA; IL-6 SIGNAL TRANSDUCER; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NEURONS;

ANIMALS; B-LYMPHOCYTES; CELL DEATH; CYTOKINES; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROGLIA; NEURONS; SIGNAL TRANSDUCTION;

EID: 84884904422     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.06.001     Document Type: Review

References (52)

1. R. Lisak, R. Heinze, G. Falk, and M. Kies Search for anti-encephalitogen antibody in human demyelinative diseases Neurology 18 1968 122 128
2. R. Lisak, R. Heinze, M. Kies, and E. Alvord Antibodies to encephalitogenic basic protein in experimental allergic encephalomyelitis Proc Soc Exp Biol Med 130 1969 814 818
3. R. Lisak, G. Falk, R. Heinze, M. Kies, and E. Alvord Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein J Immunol 1970 1435 1446
4. P. Behan, N. Geschwind, J. Lamarche, R. Lisak, and M. Kies Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis Lancet 2 1968 1009 1012
5. R. Lisak, and B. Zweiman In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitis Cell Immunol 11 1974 212 220
6. R. Lisak, B. Zweiman, and M. Norman Antimyelin antibodies in neurologic disease: immunofluorescent demonstration Arch Neurol 32 1975 163 167
7. M. Raff, R. Mirsky, K. Fields, R. Lisak, S. Dorfman, and D. Silberberg Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture Nature 274 1978 813 816
8. P. Kennedy, R. Lisak, and M. Raff Cell type-specific markers for human glial and neuronal cells in culture Lab Invest 43 1980 342 351
9. B. Sajja, J. Wolinsky, and P. Narayana Proton magnetic resonance spectroscopy in multiple sclerosis Neuroimaging Clin N Am 19 2009 45 58
10. L. Whitney, K. Becker, N. Tresser, C. Caballero-Ramos, P. Munson, and V. Prabhu Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays Ann Neurol 46 1999 425 428
11. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, and H. Garren Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat Med 8 2002 500 508
12. L. Tajouri, A. Mellick, K. Ashton, A. Tannenberg, R. Nagra, and W. Tourtellotte Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis Brain Res Mol Brain Res 119 2003 170 183
13. M. Mycko, R. Papoian, U. Boschert, C. Raine, and K. Selmaj cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity Brain 126 2003 1048 1057
14. M. Mycko, R. Papoian, U. Boschert, C. Raine, and K. Selmaj Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis Clin Neurol Neurosurg 106 2004 223 229
15. R. Lindberg, C. De Groot, U. Certa, R. Ravid, F. Hoffmann, and L. Kappos Multiple sclerosis as a generalized CNS disease - comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS J Neuroimmunol 152 2004 154 167
16. I. Allen, S. McQuaid, M. Mirakhur, and G. Nevin Pathological abnormalities in the normal-appearing white matter in multiple sclerosis Neurol Sci 22 2001 141 144
17. I. Allen, and S. McKeown A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis J Neurol Sci 41 1979 81 91
18. U. Graumann, R. Reynolds, A.J. Steck, and N. Schaeren-Wiemers Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult Brain Pathol 13 2003 554 573
19. R. Lisak, J. Benjamins, B. Bealmear, B. Yao, S. Land, and L. Nedelkoska Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures Mult Scler 12 2006 149 168
20. R. Lisak, J. Benjamins, B. Bealmear, L. Nedelkoska, B. Yao, and S. Land Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins J Neuroinflammation 4 2007 30
21. R. Lisak, J. Benjamins, B. Bealmear, L. Nedelkoska, D. Studzinski, and R. Retland Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures J Neuroinflammation 6 2009 4
22. J. Rose, B. Bealmear, N. Nedelkoska, D. Studzinski, R. Lisak, and J. Benjamins Cytokines decrease expression of interleukin-6 signal transducer and leptin receptor in central nervous system glia J Neurosci Res 87 2009 3098 3106
23. S. Hinchliffe, O. Spiller, N. Rushmere, and B. Morgan Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55) J Immunol 161 1998 5695 5703
24. A. Janjour, S. Bull, M. Almasieh, S. Rajasekharan, K. Baker, and J. Mui Maintenance of axo-oligodendroglial paranodal junctions requires DCC and netrin-1 J Neurosci 28 2008 11003 11014
25. S. Rajasekharan, K. Baker, K. Horn, A. Jarjour, J. Antel, and T. Kennedy Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA Development 136 2009 415 426
26. T. Kondo, and M. Raff Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells Genes Dev 18 2004 2963 2972
27. C. Gregg Pregnancy, prolactin and white matter regeneration J Neurol Sci 285 2009 22 27 [Review]
28. S. Zhornitsky, V. Yong, S. Weiss, and L. Metz Prolactin in multiple sclerosis Mult Scler 19 2013 15 23
29. J.B. Grinspan, E. Edell, D.F. Carpio, J.S. Beesley, L. Lavy, and D. Pleasure Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage J Neurobiol 43 2000 1 17
30. M. Yanagisawa, T. Takizawa, W. Ochiai, A. Uemura, K. Nakashima, and T. Taga Fate alteration of neuroepithelial cells from neurogenesis to astrocytogenesis by bone morphogenetic proteins Neurosci Res 41 2001 391 396
31. L. Tajouri, A. Mellick, K. Ashton, A. Tannenberg, R. Nagra, and W. Tourtellotte Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis Brain Res Mol Brain Res 119 2003 170 183
32. R. Dutta, J. McDonough, X. Yin, J. Peterson, A. Chang, and T. Torres Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 57 2006 478 489
33. R. Dutta, and B. Trapp Gene expression profiling in multiple sclerosis brain Neurobiol Dis 45 2010 108 114 [Review]
34. R. Dutta, J. McDonough, A. Chang, L. Swamy, A. Siu, and G. Kidd Activation of the ciliary neurotrophic factor (CNTF) signaling pathway in cortical neurons of multiple sclerosis patients Brain 130 2007 2566 2576
35. D. Mahad, I. Ziabreva, H. Lassmann, and D. Turnbull Mitochondrial defects in acute multiple sclerosis lesions Brain 131 2008 1722 1735
36. R. Lisak, L. Nedelkoska, D. Studzinski, B. Bealmear, W. Xu, and J. Benjamins Cytokines regulate neuronal gene expression: differential effects of Th1, Th2 and monocyte/macrophage cytokines J Neuroimmunol 238 2011 19 33
37. D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Köhler, and A.M. Cesura Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells J Neurochem 66 1996 996 1004
38. K. Rejdak, A. Petzold, T. Kocki, J. Kurzepa, P. Grieb, and W. Turski Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis J Neural Transm 114 2007 1011 1015
39. Y. Wang, M. Lawson, R. Dantzer, and K. Kelley LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia Brain Behav Immun 24 2010 201 209
40. N. Braidy, G. Guillemin, and R. Grant Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons Int J Tryptophan Res 4 2011 29 37
41. J. Gruen, and S. Weissman Evolving views of the major histocompatibility complex Blood 90 1997 4252 4265
42. J. Herrmann, L. Lerman, and A. Lerman Ubiquitin and ubiquitin-like proteins in protein regulation Circ Res 100 2007 1276 1291
43. P. Gong, A. Canaan, B. Wang, J. Leventhal, A. Snyder, and V. Nair The ubiquitin-like protein FAT10 mediates NF-kappaB activation J Am Soc Nephrol 21 2010 316 326
44. E. Bozkulak, and G. Weinmaster Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling Mol Cell Biol 29 2009 5679 5695
45. K. Jepsen, D. Solum, T. Zhou, R.J. McEvilly, H.J. Kim, and C.K. Glass SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron Nature 450 2007 415 419
46. R. Lisak, J. Benjamins, L. Nedelkoska, J. Barger, S. Ragheb, and B. Fan Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro J Neuroimmunol 246 2012 85 95
47. A. Bar-Or, E. Oliveira, D. Anderson, J. Krieger, M. Duddy, and K. O'Connor Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state J Immunol 167 2001 5669 5677
48. M. Duddy, A. Alter, and A. Bar-Or Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 172 2004 3422 3427
49. M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman, and H. Atkins Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis J Immunol 178 2007 6092 6099
50. A. Bar-Or, L. Fawaz, B. Fan, P.J. Darlington, A. Rieger, and C. Ghorayeb Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol 67 2010 452461
51. K. Selmaj, and C. Raine Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro Ann Neurol 23 1988 339 346
52. K. Selmaj, C. Raine, M. Farooq, W. Norton, and C. Brosnan Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin J Immunol 147 1991 1522 1529